Agaris™ is a plant biotechnology platform developed by Crown Organogenesis Protocols Inc., dedicated to advancing the science and commercial scalability of high-value tropical crops.
Through the integration of tissue culture, elite genotype selection, and structured agroforestry deployment, Agaris™ transforms superior plant genetics into traceable, disease-free, and plantation-ready plantlets designed for long-term productivity and sustainability.
Our Vision
To become a leading biotechnology platform for elite tropical plant genetics, enabling the sustainable production of high-value aromatic, medicinal, and forestry crops for global markets.
Our Mission
Agaris™ exists to bridge laboratory science with real-world agricultural deployment by delivering:
- Elite clonal plantlets with verified genetic fidelity
- Advanced tissue culture and micropropagation systems
- Structured nursery and plantation protocols
- Data-driven plantation performance monitoring
- ESG-aligned agroforestry development
By integrating biotechnology with sustainable plantation management, Agaris™ aims to create predictable, scalable, and environmentally responsible crop production systems.
Strategic Goals (3–5 Years)
- Scale propagation capacity for agarwood and companion crops
- Develop proprietary high-yielding genotypes
- Establish partnerships with plantation investors domestically and internationally
- Expand R&D to include genetic improvement and disease resistance
- Support Crown Agroforestry Group’s integrated value-chain expansion
COPI is the innovation engine for high-value crop propagation, delivering the science that powers sustainable and profitable agroforestry.